Survey on the Pharmacy Follow-up of Alli Purchasers

Survey on the Pharmacy Follow up of Alli Purchasers

To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.

Study Overview

• Status: Completed
• Conditions: Overweight
• Intervention / Treatment: Drug: Orlistat

• Study Type: Observational
• Enrollment (Actual): 80

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Consumers purchasing orlistat in a pharmacy setting

Description

Inclusion Criteria:

• Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
60 mg Orlistat; Purchased by consumer	Drug: Orlistat; 60 mg

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Change in Physical activity	baseline to 1 year

Secondary Outcome Measures

Outcome Measure	Time Frame
Change in dietary behavior	baseline to 1 year
Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)	baseline to 1 year
Satisfaction with management (i.e., results on weight and treatment comfort)	baseline to 1 year

Collaborators and Investigators

• Sponsor: GlaxoSmithKline

Study record dates

Study Major Dates

• Study Start: January 1, 2010
• Primary Completion (Actual): December 1, 2010
• Study Completion (Actual): December 1, 2010

Study Registration Dates

• First Submitted: March 29, 2010
• First Submitted That Met QC Criteria: June 30, 2011
• First Posted (Estimate): July 4, 2011

Study Record Updates

• Last Update Posted (Estimate): October 29, 2012
• Last Update Submitted That Met QC Criteria: October 25, 2012
• Last Verified: October 1, 2012

More Information

Terms related to this study

• Keywords: overweight; orlistat; behavior modification
• Additional Relevant MeSH Terms: Body Weight; Overweight; Molecular Mechanisms of Pharmacological Action; Enzyme Inhibitors; Lipid Regulating Agents; Anti-Obesity Agents; Orlistat
• Other Study ID Numbers: W5350856